CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2021 - 2023)
CollPlant Biotechnologies (CLGN) reported Change in Acquisitions & Divestments of -$211000.0 for Q4 2023, up 98.94% on a YoY basis from -$106059.5 in Q4 2022, and up 98.94% quarter-over-quarter from -$20.0 million in Q4 2022.
CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
CollPlant Biotechnologies has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at -$211000.0 in Q4 2023.
- For the quarter ending Q4 2023, Change in Acquisitions & Divestments rose 98.94% year-over-year to -$211000.0; the trailing twelve-month figure through Dec 2024 stood at -$211000.0 (up 98.96% YoY), and the FY2024 full-year result was -$57000.0, up 78.89% from the prior year.
- Change in Acquisitions & Divestments for Q4 2023 stood at -$211000.0, up from -$20.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was -$211000.0 in Q4 2023, with the low at -$30.0 million in Q1 2021.
- Historically, Change in Acquisitions & Divestments has averaged -$20.1 million across 3 years, with a median of -$25.0 million in 2021.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments soared 33.33% — and 2023, when it jumped 98.94%.
- CollPlant Biotechnologies' Change in Acquisitions & Divestments stood at -$30.0 million in 2021, then jumped by 33.33% to -$20.0 million in 2022, then jumped by 98.94% to -$211000.0 in 2023.
- The last three Change in Acquisitions & Divestments figures came in at -$211000.0 (Q4 2023), -$20.0 million (Q4 2022), and -$30.0 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2022 | -20.00 Mn |
| Dec 31, 2022 | -20.00 Mn |
| Dec 31, 2021 | -30.00 Mn |
| Dec 31, 2021 | -30.00 Mn |
| Mar 31, 2021 | -30.00 Mn |
| Mar 31, 2021 | -30.00 Mn |